The AGA report acknowledges that infection risk may be linked to the complexity of the scopes, a risk which remains despite proper reprocessing protocols. The AGA, along with its sister GI societies, is working with the FDA device branch and device manufacturers to solve the issue.
New FDA guidelines are expected this year.
More articles on gastroenterology:
11 gastroenterologists serving as ASC medical directors
FDA approves pacemaker-like device to treat obesity
Colorectal cancer mortality by tumor marker: 9 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.